Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1973 Jun;14(2):159–167.

Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts

P Hersey, I C M MacLennan, A C Campbell, R Harris, C B Freeman
PMCID: PMC1553784  PMID: 4577850

Abstract

Antibodies which are to induce the killing of allogeneic myeloblasts by normal lymphoid cells have been found in a high proportion of patients with acute myeloid leukaemia. The cytotoxic mechanism induced by this antibody activity is shown to be highly effective in terms of the number of myeloblasts which can be killed by a given number of lymphoid cells and the antibody concentration needed to induce killing.

Reasons for the in vivo failure of this cytotoxic mechanism, assuming that antibodies occur against autologous myeloblasts, are suggested by studies in which the cytotoxic lymphoid population has been monitored serially. Some patients are shown to have almost undetectable levels of cytotoxic effector cell activity. A further reason for the failure of this mechanism related to `blocking activity' in the serum is being investigated. Preliminary results suggest that assay of this antibody activity against myeloblasts may also be of value in following the response to immunotherapy and in providing early warning of relapse.

It is suggested that the demonstration of antibody-dependent lymphocyte activity against acute myeloid leukaemic cells provides an additional insight into this disease which may have important implications in management and therapy of acute myeloid leukaemia.

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  2. COULSON A. S., CHALMERS D. G. SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD. Lancet. 1964 Feb 29;1(7331):468–469. doi: 10.1016/s0140-6736(64)90799-8. [DOI] [PubMed] [Google Scholar]
  3. Crowther D., Powles R. L., Bateman C. J., Beard M. E., Gauci C. L., Wrigley P. F., Malpas J. S., Fairley G. H., Scott R. B. Management of adult acute myelogenous leukaemia. Br Med J. 1973 Jan 20;1(5846):131–137. doi: 10.1136/bmj.1.5846.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dore J. F., Motta R., Marholev L., Hrsak I., Colas de la Noue H., Seman G., De Vassal F., Mathé G. New antigens in human leukaemic cells and antibody in the serum of leukaemic patients. Lancet. 1967 Dec 30;2(7531):1396–1398. doi: 10.1016/s0140-6736(67)93027-9. [DOI] [PubMed] [Google Scholar]
  5. Fridman W. H., Kourilsky F. M. Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature. 1969 Oct 18;224(5216):277–279. doi: 10.1038/224277a0. [DOI] [PubMed] [Google Scholar]
  6. Harding B., Pudifin D. J., Gotch F., MacLennan I. C. Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol. 1971 Jul 21;232(29):80–82. doi: 10.1038/newbio232080a0. [DOI] [PubMed] [Google Scholar]
  7. Hellström I., Sjögren H. O., Warner G., Hellström K. E. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971 Mar 15;7(2):226–237. doi: 10.1002/ijc.2910070206. [DOI] [PubMed] [Google Scholar]
  8. Lamon E. W., Skurzak H. M., Klein E., Wigzell H. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med. 1972 Nov 1;136(5):1072–1079. doi: 10.1084/jem.136.5.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leventhal B. G., Halterman R. H., Rosenberg E. B., Herberman R. B. Immune reactivity of leukemia patients to autologous blast cells. Cancer Res. 1972 Sep;32(9):1820–1825. [PubMed] [Google Scholar]
  10. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  11. MacLennan I. C. Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol. 1972 Feb;10(2):275–283. [PMC free article] [PubMed] [Google Scholar]
  12. MacLennan I. C., Loewi G., Harding B. The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes. Immunology. 1970 Mar;18(3):397–404. [PMC free article] [PubMed] [Google Scholar]
  13. MacLennan I. C., Loewi G., Howard A. A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes. Immunology. 1969 Dec;17(6):897–910. [PMC free article] [PubMed] [Google Scholar]
  14. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  15. Pegrum G. D., Balfour I. C., Evans C. A., Middleton V. L. HL-A typing of "leukaemic" cells. Lancet. 1971 Apr 24;1(7704):852–853. doi: 10.1016/s0140-6736(71)91511-x. [DOI] [PubMed] [Google Scholar]
  16. Powles R. L., Balchin L. A., Fairley G. H., Alexander P. Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J. 1971 Feb 27;1(5747):486–489. doi: 10.1136/bmj.1.5747.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosenberg E. B., Herberman R. B., Levine P. H., Halterman R. H., McCoy J. L., Wunderlich J. R. Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer. 1972 May 15;9(3):648–658. doi: 10.1002/ijc.2910090323. [DOI] [PubMed] [Google Scholar]
  18. Yoshida T. O., Imai K. Auto-antibody to human leukemic cell membrane as detected by immune adherence. Rev Eur Etud Clin Biol. 1970 Jan;15(1):61–65. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES